C. Curiel-lewandrowski, C. Kim, and S. Swetter, Survival Is Not the Only Valuable End Point in Melanoma Screening, Journal of Investigative Dermatology, vol.132, issue.5, pp.1332-1337, 2012.
DOI : 10.1038/jid.2012.3

A. Piris, A. Lobo, and L. Duncan, Melanoma Staging, Dermatologic Clinics, vol.30, issue.4, pp.581-592, 2012.
DOI : 10.1016/j.det.2012.06.001

F. Grange, C. Barbe, and F. Aubin, Clinical and Sociodemographic Characteristics Associated With Thick Melanomas, Archives of Dermatology, vol.148, issue.12, pp.1-7, 2012.
DOI : 10.1001/archdermatol.2012.2937
URL : https://hal.archives-ouvertes.fr/hal-00771936

W. Weyers, The ???epidemic??? of melanoma between under- and overdiagnosis, Journal of Cutaneous Pathology, vol.13, issue.1, pp.9-16, 2012.
DOI : 10.1111/j.1600-0560.2011.01831.x

G. Lyratzopoulos, G. Abel, and C. Brown, Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer, Annals of Oncology, vol.24, issue.3, pp.843-850, 2013.
DOI : 10.1093/annonc/mds526

F. Birch-johansen, G. Hvilsom, and T. Kjaer, Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994???2003, European Journal of Cancer, vol.44, issue.14, pp.2043-2049, 1994.
DOI : 10.1016/j.ejca.2008.06.016

M. Rutherford, L. Ironmonger, and N. Ormiston-smith, Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma, British Journal of Cancer, vol.9, pp.116-123, 2015.
DOI : 10.1111/j.1600-0560.2011.01831.x

D. Van-durme, J. Ferrante, and N. Pal, Demographic Predictors of Melanoma Stage at Diagnosis, Archives of Family Medicine, vol.9, issue.7, pp.606-611, 2000.
DOI : 10.1001/archfami.9.7.606

M. Mandal-a, G. Imberti, and D. Piazzalunga, Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma, Mayo Clinic Proceedings, vol.86, issue.2, pp.113-119, 2011.
DOI : 10.4065/mcp.2010.0671

A. Geller, S. Swetter, and S. Oliveria, Reducing mortality in individuals at high risk for advanced melanoma through education and screening, Journal of the American Academy of Dermatology, vol.65, issue.5, pp.87-94, 2011.
DOI : 10.1016/j.jaad.2011.05.045

R. Andrulonis, A. Secrest, and S. Mcguire, The Influence of Age and Sex on Reasons for Seeking and Expected Benefits of Skin Cancer Screening, Archives of Dermatology, vol.146, issue.10, pp.1097-1102, 2010.
DOI : 10.1001/archdermatol.2010.254

C. Merseyside and . Network, Targeting men aged 50þ to increase early detection of melanoma local campaign planning guide. [Internet]; [cited 2014 Nov 1] Available from: http://info.cancerresearchuk .org/prod_consump/groups, 2014.

C. Rat, G. Quereux, and C. Riviere, Targeted Melanoma Prevention Intervention: A Cluster Randomized Controlled Trial, The Annals of Family Medicine, vol.12, issue.1, pp.21-28, 2014.
DOI : 10.1370/afm.1600

C. Rat, G. Quereux, and C. Grimault, Melanoma incidence and patient compliance in a targeted melanoma screening intervention. One-year follow-up in a large French cohort of high-risk patients, European Journal of General Practice, vol.20, issue.2, pp.124-130, 2015.
DOI : 10.1002/cncr.24162

G. Qu-ereux, N. 'guyen, J. Cary, and M. , Validation of the Self-Assessment of Melanoma Risk Score for a melanoma-targeted screening, European Journal of Cancer Prevention, vol.21, issue.6, pp.588-595, 2012.
DOI : 10.1097/CEJ.0b013e328353ed68

V. Cokkinides, A. Geller, and A. Jemal, Trends in melanoma mortality among non-Hispanic whites by educational attainment, Arch Dermatol, vol.148, pp.587-591, 1993.

P. Boxer, S. Wilson, and N. Mathers, Short report: how often do UK primary care trials face recruitment delays? Fam Pract, pp.601-603, 2007.

J. Van-der-wouden, A. Blankenstein, and M. Huibers, Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research, Journal of Clinical Epidemiology, vol.60, issue.8, pp.819-824, 2007.
DOI : 10.1016/j.jclinepi.2006.11.010

M. Montella, A. Crispo, and M. Grimaldi, An Assessment of Factors Related to Tumor Thickness and Delay in Diagnosis of Melanoma in Southern Italy, Preventive Medicine, vol.35, issue.3, pp.271-277, 2002.
DOI : 10.1006/pmed.2002.1067

M. Richard, J. Grob, and M. Avril, Delays in diagnosis and melanoma prognosis (I): the role of patients

J. Baumert, G. Plewig, and M. Volkenandt, Factors associated with a high tumour thickness in patients with melanoma, British Journal of Dermatology, vol.64, issue.5, pp.938-944, 2007.
DOI : 10.1097/00008469-200202000-00007

E. Gonzalez, J. Ferrante, and D. Van-durme, Comorbid Illness and the Early Detection of Cancer, Southern Medical Journal, vol.94, issue.9, pp.913-920, 2001.
DOI : 10.1097/00007611-200194090-00021

R. Mccarney, J. Warner, and S. Iliffe, The Hawthorne Effect: a randomised, controlled trial, BMC Medical Research Methodology, vol.344, issue.3, p.30, 2007.
DOI : 10.1056/NEJM200105243442106

A. Simon, J. Waller, and K. Robb, Patient Delay in Presentation of Possible Cancer Symptoms: The Contribution of Knowledge and Attitudes in a Population Sample from the United Kingdom, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.9, pp.2272-2277, 2010.
DOI : 10.1158/1055-9965.EPI-10-0219

R. Br?-anstr?-om, S. Kristjansson, and H. Ull-en, Risk perception, optimistic bias, and readiness to change sun related behaviour, The European Journal of Public Health, vol.16, issue.5, pp.492-497, 2006.
DOI : 10.1093/eurpub/cki193

L. Hvidberg, A. Pedersen, and C. Wulff, Cancer awareness and socio-economic position: results from a population-based study in Denmark, BMC Cancer, vol.11, issue.Suppl 1, p.581, 2014.
DOI : 10.1080/10810730600637426

M. Falk and H. Magnusson, Sun protection advice mediated by the general practitioner: an effective way to achieve long-term change of behaviour and attitudes related to sun exposure? Scand J Prim Health Care, pp.135-143, 2011.

M. Søgaard, R. Thomsen, and K. Bossen, The impact of comorbidity on cancer survival: a review, Clinical Epidemiology, vol.5, pp.3-29, 2013.
DOI : 10.2147/CLEP.S47150

R. Kundu, Barriers in Melanoma Detection in Ethnic Minorities, Archives of Dermatology, vol.148, issue.7, pp.801-802, 1998.
DOI : 10.1001/archdermatol.2012.910

S. Fleming, H. Pursley, and B. Newman, Comorbidity as a Predictor of Stage of Illness for Patients With Breast Cancer, Medical Care, vol.43, issue.2, pp.132-140, 2005.
DOI : 10.1097/00005650-200502000-00006

R. Roetzheim, J. Lee, and J. Ferrante, The Influence of Dermatologist and Primary Care Physician Visits on Melanoma Outcomes Among Medicare Beneficiaries, The Journal of the American Board of Family Medicine, vol.26, issue.6, pp.637-647, 2013.
DOI : 10.3122/jabfm.2013.06.130042

K. Stitzenberg, N. Thomas, and K. Dalton, Distance to Diagnosing Provider as a Measure of Access for Patients With Melanoma, Archives of Dermatology, vol.143, issue.8, pp.991-998, 2007.
DOI : 10.1001/archderm.143.8.991

O. Keefe, D. Jensen, and J. , The Relative Persuasiveness of Gain-Framed Loss-Framed Messages for Encouraging Disease Prevention Behaviors: A Meta-Analytic Review, Journal of Health Communication, vol.66, issue.7, pp.623-644, 2007.
DOI : 10.1111/j.1559-1816.1990.tb00426.x

K. Gallagher and J. Updegraff, Health Message Framing Effects on Attitudes, Intentions, and Behavior: A Meta-analytic Review, Annals of Behavioral Medicine, vol.133, issue.11, pp.101-116, 2012.
DOI : 10.1007/s12160-011-9308-7

L. Camilloni, E. Ferroni, and B. Cendales, Methods to increase participation in organised screening programs: a systematic review, BMC Public Health, vol.30, issue.6780, p.464, 2013.
DOI : 10.1006/pmed.1999.0603

R. Raine, S. Duffy, and J. Wardle, Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening, British Journal of Cancer, vol.114, issue.3, pp.321-326, 2016.
DOI : 10.1258/jms.2010.009101